Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed

Alberto Borghetti; Arturo Ciccullo; Francesca Lombardi; Diana Giannarelli; Rosa Anna Passerotto; Francesco Lamanna; Antonella Carcagnì; Damiano Farinacci; Alex Dusina; Gianmaria Baldin; Maurizio Zazzi; Simona Di Giambenedetto

doi:10.1093/ofid/ofae198

Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed

Alberto Borghetti
, Arturo Ciccullo
, Francesca Lombardi
, Diana Giannarelli
, Rosa Anna Passerotto
, Francesco Lamanna
, Antonella Carcagnì
, Damiano Farinacci
, Alex Dusina
, Gianmaria Baldin
, Maurizio Zazzi
, Simona Di Giambenedetto

Risultato della ricerca: Contributo in rivista › Articolo

Lingua originale	Inglese
pagine (da-a)	N/A-N/A
Rivista	Open Forum Infectious Diseases
Volume	11
DOI	https://doi.org/10.1093/ofid/ofae198
Stato di pubblicazione	Pubblicato - 2024

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

SDG 3 Salute e benessere

Keywords

HIV
lamivudine/dolutegravir
target trial emulation
three-drug regimen
virologically suppressed

Accesso al documento

10.1093/ofid/ofae198

Altri file e collegamenti

Open Access link a IRIS PubliCatt

Cita questo

Borghetti, A., Ciccullo, A., Lombardi, F., Giannarelli, D., Passerotto, R. A., Lamanna, F., Carcagnì, A., Farinacci, D., Dusina, A., Baldin, G., Zazzi, M., & Di Giambenedetto, S. (2024). Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed. Open Forum Infectious Diseases, 11, N/A-N/A. https://doi.org/10.1093/ofid/ofae198

@article{8c72a831b9324848b13118e1d4367024,

title = "Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed",

keywords = "HIV, lamivudine/dolutegravir, target trial emulation, three-drug regimen, virologically suppressed, HIV, lamivudine/dolutegravir, target trial emulation, three-drug regimen, virologically suppressed",

author = "Alberto Borghetti and Arturo Ciccullo and Francesca Lombardi and Diana Giannarelli and Passerotto, \{Rosa Anna\} and Francesco Lamanna and Antonella Carcagn{\`i} and Damiano Farinacci and Alex Dusina and Gianmaria Baldin and Maurizio Zazzi and \{Di Giambenedetto\}, Simona",

year = "2024",

doi = "10.1093/ofid/ofae198",

language = "English",

volume = "11",

pages = "N/A--N/A",

journal = "Open Forum Infectious Diseases",

issn = "2328-8957",

publisher = "Oxford University Press",

}

Borghetti, A, Ciccullo, A, Lombardi, F, Giannarelli, D, Passerotto, RA, Lamanna, F, Carcagnì, A, Farinacci, D, Dusina, A, Baldin, G, Zazzi, M & Di Giambenedetto, S 2024, 'Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed', Open Forum Infectious Diseases, vol. 11, pagg. N/A-N/A. https://doi.org/10.1093/ofid/ofae198

TY - JOUR

T1 - Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed

AU - Borghetti, Alberto

AU - Ciccullo, Arturo

AU - Lombardi, Francesca

AU - Giannarelli, Diana

AU - Passerotto, Rosa Anna

AU - Lamanna, Francesco

AU - Carcagnì, Antonella

AU - Farinacci, Damiano

AU - Dusina, Alex

AU - Baldin, Gianmaria

AU - Zazzi, Maurizio

AU - Di Giambenedetto, Simona

PY - 2024

Y1 - 2024

KW - HIV

KW - lamivudine/dolutegravir

KW - target trial emulation

KW - three-drug regimen

KW - virologically suppressed

KW - HIV

KW - lamivudine/dolutegravir

KW - target trial emulation

KW - three-drug regimen

KW - virologically suppressed

UR - http://hdl.handle.net/10807/278227

U2 - 10.1093/ofid/ofae198

DO - 10.1093/ofid/ofae198

M3 - Article

SN - 2328-8957

VL - 11

SP - N/A-N/A

JO - Open Forum Infectious Diseases

JF - Open Forum Infectious Diseases

ER -